Company Number: 14281696

Analysis Date: 2025-07-29 19:35 UTC

1. Risk Rating: LOW
   Cooney Scientific Ltd demonstrates solid net asset growth and positive working capital over its two-year history. The company is current with filings and not in liquidation, indicating good compliance and operational continuity.

2. Key Concerns:

• High Trade Debtors: The majority of current assets in 2024 are debtors (£77,685), with minimal cash (£121), which may indicate some liquidity risk if receivables are not collected promptly.
• Modest Share Capital: The share capital of £102 is very low, which limits the equity buffer in adverse situations.
• Limited Financial History: Incorporated in 2022, the company has a short operating history, which reduces the predictability of long-term performance and risk assessment.

3. Positive Indicators:

• Improved Net Assets and Working Capital: Net assets more than doubled from £24,491 in 2023 to £52,509 in 2024, and net current assets increased to £49,498, showing financial growth and improved short-term solvency.
• No Overdue Filings or Regulatory Issues: The company is up to date with accounts and confirmation statements, reflecting good governance and compliance practices.
• Industry Position: Operating in engineering-related scientific and technical consulting activities (SIC 71122), a sector which can offer stable demand and expertise-driven revenue streams.

4. Due Diligence Notes:

• Investigate the collectability and aging profile of trade debtors to assess liquidity risk and potential bad debts.
• Review cash flow statements (not provided) to confirm operational cash generation and reliance on receivables.
• Examine contract terms and client concentration to understand revenue sustainability and debtor risk.
• Confirm if the provision for liabilities (£706 in 2024) relates to any contingent or impending obligations.
• Assess the background and experience of the sole director, James McQuat, to evaluate management capability.